Intervention not reported
LDL‐Cholesterol rosuvastatin 40 mg/day · participantswith normal or abnormal lipid profiles
1 finding from 1 review
- no estimate extracted18 studies · 3512 participantsHigh
Findings
What do systematic reviews say?
2,191 questions · 2,354 findings · 362 reviews
No studies found 323 · 13.7%GRADE not reported 382 · 16.2%Very low 555 · 23.6%Low 597 · 25.4%Moderate 345 · 14.7%High 152 · 6.5%
Intervention not reported
WDAE2 all doses · participantswith normal or abnormal lipid profiles
1 finding from 1 review
- no estimate extracted10 studies · 1330 participantsVery low
Intervention not reported
Death or lost to care · HIV infected patients
The intervention probably leads to lower death or lost to care (moderate certainty).
1 finding from 1 review
- Decentralising HIV treatment in lower‐ and middle‐income countries 2013 · Cochrane Headline outcomes onlyRR 0.46 [0.29, 0.71]4 studies · 39090 participantsModerate
Intervention not reported
Lost to care · HIV infected patients
The intervention may leads to lower lost to care (low certainty).
1 finding from 1 review
- Decentralising HIV treatment in lower‐ and middle‐income countries 2013 · Cochrane Headline outcomes onlyRR 0.55 [0.45, 0.69]4 studies · 39090 participantsLow
Intervention not reported
Death · HIV infected patients
The intervention may leads to lower death (low certainty).
1 finding from 1 review
- Decentralising HIV treatment in lower‐ and middle‐income countries 2013 · Cochrane Headline outcomes onlyRR 0.34 [0.13, 0.87]4 studies · 39090 participantsLow
Intervention not reported
Death or lost to care · HIV infected patients
It is very uncertain whether the intervention changes death or lost to care (very low certainty).
1 finding from 1 review
- Decentralising HIV treatment in lower‐ and middle‐income countries 2013 · Cochrane Headline outcomes onlyRR 0.7 [0.47, 1.02]4 studies · 56360 participantsVery low
Intervention not reported
Lost to care · HIV infected patients
The intervention probably leads to lower lost to care (moderate certainty).
1 finding from 1 review
- Decentralising HIV treatment in lower‐ and middle‐income countries 2013 · Cochrane Headline outcomes onlyRR 0.3 [0.17, 0.54]4 studies · 56360 participantsModerate
Intervention not reported
Death · HIV infected patients
It is very uncertain whether the intervention changes death (very low certainty).
1 finding from 1 review
- Decentralising HIV treatment in lower‐ and middle‐income countries 2013 · Cochrane Headline outcomes onlyRR 1.1 [0.63, 1.92]4 studies · 55099 participantsVery low
Intervention not reported
Death or lost to care · HIV‐infected patients
The intervention showed no clear difference in death or lost to care (moderate certainty).
1 finding from 1 review
- Decentralising HIV treatment in lower‐ and middle‐income countries 2013 · Cochrane Headline outcomes onlyRR 0.95 [0.62, 1.46]2 studies · 709 participantsModerate
Intervention not reported
Lost to care · HIV‐infected patients
The intervention showed no clear difference in lost to care (moderate certainty).
1 finding from 1 review
- Decentralising HIV treatment in lower‐ and middle‐income countries 2013 · Cochrane Headline outcomes onlyRR 0.81 [0.3, 2.21]2 studies · 709 participantsModerate
Intervention not reported
Death · HIV‐infected patients
The intervention showed no clear difference in death (moderate certainty).
1 finding from 1 review
- Decentralising HIV treatment in lower‐ and middle‐income countries 2013 · Cochrane Headline outcomes onlyRR 1.03 [0.64, 1.65]2 studies · 709 participantsModerate